384
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Is it over for ezetimibe?

&
Pages 781-783 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Luis Rodriguez Padial. (2010) The ENHANCE trial: analysis and clinical significance. Clinical Lipidology 5:2, pages 161-166.
Read now

Articles from other publishers (6)

Michel Farnier, Eric Bruckert, Catherine Boileau & Michel Krempf. (2013) Diagnostic et traitement des hypercholestérolémies familiales (HF) chez l’adulte : recommandations de la Nouvelle société française d’athérosclérose (NSFA). La Presse Médicale 42:6, pages 930-950.
Crossref
Peter P. Toth, Christie M. Ballantyne, Michael H. Davidson, Joanne E. Tomassini, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, X. Henry Hu & Kaan Tunceli. (2012) Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction. Journal of Clinical Lipidology 6:2, pages 180-191.
Crossref
Jennifer G. Robinson & Anne C. Goldberg. (2011) Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of Clinical Lipidology 5:3, pages S18-S29.
Crossref
Lorenzo Iughetti, Patrizia Bruzzi & Barbara Predieri. (2010) Evaluation and management of hyperlipidemia in children and adolescents. Current Opinion in Pediatrics 22:4, pages 485-493.
Crossref
Joseph S Thompson, Aditya Sood & Rohit Arora. (2010) Statins and Cancer: A Potential Link?. American Journal of Therapeutics 17:4, pages e100-e104.
Crossref
Byron F. Vandenberg & Jennifer Robinson. (2010) Management of the Patient with Statin Intolerance. Current Atherosclerosis Reports 12:1, pages 48-57.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.